Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
This study has been terminated.
Study NCT00850499
Information provided by Millennium Pharmaceuticals, Inc.
First Received on February 24, 2009.
Last Updated on December 10, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
